期刊
GYNECOLOGIC ONCOLOGY
卷 80, 期 3, 页码 355-358出版社
ACADEMIC PRESS INC
DOI: 10.1006/gyno.2000.6014
关键词
CD44 V6; endometrial cancer; prognosis
Objective. We evaluated the prognostic significance of CD44 isoform CD44 V6 in endometrial cancer. Method. Immunohistochemistry was used to determine the expression of CD44 V6 in 78 randomly selected endometrial cancer specimens. Results. CD44 V6 was detected in 53% (41/78) of the tumor samples. Clinicopathological evaluation revealed an inverse correlation with CD44 V6 expression and conventional poor prognosticators such as lower segment involvement, nuclear and structural grade, myometrial invasion, serosal involvement, lymph-vascular space invasion, and adnexal metastasis. Furthermore, the CD44 V6-negative group was found to be associated have a higher recurrence rate and a shorter disease-free survival. Conclusion. These findings indicate that absence of CD44 V6 expression in cases of endometrial cancer might be coupled with a more aggressive course. (C) 2001 Academic Press.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据